Bicyclic heteroaromatic compounds as kinase inhibitors
申请人:Brookings Christopher Daniel
公开号:US20060122212A1
公开(公告)日:2006-06-08
A series of 5-6 fused ring bicyclic heteroaromatic derivatives, based in particular on the 5-oxo-4,5-dihydro-1H-pyrrolo[3,2-b]pyridine ring system, being inhibitors of p38 kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.
BICYCLIC HETEROAROMATIC COMPOUNDS AS KINASE INHIBITORS
申请人:Celltech R & D Limited
公开号:EP1549648A1
公开(公告)日:2005-07-06
US7456286B2
申请人:——
公开号:US7456286B2
公开(公告)日:2008-11-25
[EN] BICYCLIC HETEROAROMATIC COMPOUNDS AS KINASE INHIBITORS<br/>[FR] COMPOSES HETEROAROMATIQUES BICYCLIQUES UTILISES EN TANT QU'INHIBITEUR DE KINASE
申请人:CELLTECH R&D LTD
公开号:WO2004031188A1
公开(公告)日:2004-04-15
A series of 5-6 fused ring bicyclic heteroaromatic derivatives, based in particular on the 5-oxo-4,5-dihydro-1H-pyrrolo[3,2-b]pyridine ring system, being inhibitors of p38 kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.